ABT

Mateus Fernando

Known title: SENIOR VICE PRESIDENTCIK: 0001895703

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Abbott Labs launches Ensure Max Protein as earnings preview approaches. Abbott Laboratories introduced a new high‑protein nutritional drink, Ensure Max Protein, expanding its consumer health lineup. At the same time, investors are looking ahead to the company's third‑quarter earnings, with analysts focusing on revenue and earnings per share estimates. TD Cowen reaffirmed its positive view of Abbott, keeping a $135 price target, which aligns with the analyst consensus range. The stock is currently near a long‑standing support level around $99.90.

this person other insiders at ABT

Transaction History

ABT▼ Sell$102K
ABT▼ Sell$71K
ABT▼ Sell$55K
ABT▲ Buy$0
ABT▼ Sell$268K
ABT▼ Sell$103K
ABT▼ Sell$82K
ABT▼ Sell$69K
ABT▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.